The veterinary infectious disease diagnostics market has seen considerable growth due to a variety of factors.
• In recent times, there has been a significant growth in the size of the veterinary infectious disease diagnostics market. The market is expected to expand from $1.93 billion in 2024 to $2.11 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.1%.
Reasons behind such growth in the historic period include an upward trend in pet ownership, advancements in veterinary medicine, a growing trend of treating pets as family members, and supportive regulatory measures.
The veterinary infectious disease diagnostics market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for veterinary infectious disease diagnostics is anticipated to witness robust expansion in the ensuing years, with an estimated value of $3.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.8%.
Factors such as the emergence of new diseases, enhanced research and development efforts, the globalization of veterinary practices, and an increasing livestock population contribute to the growth in this forecast period. The notable trends expected during this period are technological advancements, fast adoption of point-of-care testing, integration of molecular diagnostics, digital transformations in veterinary healthcare, product portfolio expansion, collaborative ventures and partnerships, and the availability of tailored diagnostics for various animal species.
The surge in cases of transboundary and zoonotic diseases, including rabies, is anticipated to fuel the expansion of the veterinary infectious disease diagnostics market. Zoonoses are infections and illnesses that can spontaneously transfer between humans and vertebrates. Veterinary infectious disease diagnostic tools are employed to identify rabies in pets and other animals, enhancing their capability to prevent fatal outcomes. For example, in 2022, the World Health Organization (WHO), a Switzerland-based global agency, reported the presence of rabies disease in over 150 nations and territories. Dogs are the principal cause of rabies-related human fatalities, contributing to as much as 99% of all transmissions of rabies. Approximately 40% of those bitten by possibly rabid animals are children under 15. This infection claims tens of thousands of lives annually, primarily in Asia and Africa. Hence, the escalating prevalence of transboundary and zoonotic diseases is a significant factor propelling the growth of the veterinary infectious disease diagnostics market.
The veterinary infectious disease diagnostics market covered in this report is segmented –
1) By Infection Type: Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections
2) By Animal Type: Companion Animal, Food-Producing Animals
3) By Technology: Immunodiagnostics, Molecular Diagnostic, Other Technologies
4) By End User: Reference Laboratories, Veterinary Hospitals And Clinics, Point Of Care, Research Institutes And Universities, Other End Users
Subsegments:
1) By Viral Infections: Canine Parvovirus, Feline Leukemia Virus, Avian Influenza Virus
2) By Bacterial Infections: Canine Bordetella, Leptospirosis, Salmonellosis
3) By Parasitic Infections: Fleas And Ticks, Heartworm, Giardia
4) By Other Infections: Fungal Infections, Mycoplasma Infections
The predominant trend gaining traction in the veterinary infectious disease diagnostics market is the advent of technological advancements. Many primary players in this market are ushering in inventive technological solutions to maintain their market standing. For example, Merck Animal Health, an American organization specializing in the production of animal medications, launched SenseHub Feedlot in February 2022 which is based on electronic ear tag technology. SenseHub Feedlot comprises a reusable ear tag and an integrated antenna and an infrared thermistor. These tools collectively capture, store, and disseminate data from a gateway to a data platform. SenseHub Feedlot is a tech-driven solution facilitates more rapid illness detection, more dependable disease diagnosis and earlier disease identification, allowing for more efficient pain management in cattle compared to traditional visual inspection.
Major companies operating in the veterinary infectious disease diagnostics market include:
• Zoetis Inc.
• IDEXX Laboratories Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN N. V.
• IDvet
• NEOGEN Corporation
• INDICAL BIOSCIENCE GmbH
• Randox Laboratories Ltd
• Creative Diagnostics
• Heska Corporation
• Chembio Diagnostics Inc.
• URIT Medical Electronic Co. Ltd.
• NTBIO Diagnostics Inc.
• Bio-X Diagnostics
• Agrolabo Spa
• Virbac
• Covetrus Inc.
• Biomerieux S. A.
• Bio-Rad Laboratories Inc.
• Eurofins Scientific SE
• Fujifilm Wako Pure Chemical Corporation
• GenScript Biotech Corporation
• Merck KGaA
• MP Biomedicals LLC
• Quidel Corporation
• Roche Diagnostics Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• VCA Inc.
• Vetoquinol SA
North America was the largest region in the veterinary disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa